Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Average Recommendation of "Moderate Buy" by Analysts
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) has received an average rating of "Moderate Buy" from the six research firms that are covering the company, Marketbeat Ratings reports...